Health Body Mass Index Tied to Multiple Myeloma Survival James Pereira Jan 21, 2023 Lori Solomon FRIDAY, Jan. 20, 2023 (HealthDay News) -- Underweight and severe… Read More...
Health Post-Transplant Triplet Bests Lenalidomide Maintenance Alone in Myeloma James Pereira Jan 18, 2023 Use of a triple-drug… Read More...
Health Is PFS Benefit Enough to Support Upfront Transplant in Multiple Myeloma? James Pereira Jan 12, 2023 DETERMINATION is one of many recent… Read More...
Health Microenvironment May Predict Sustained MRD Negativity in Newly Diagnosed Myeloma James Pereira Jan 5, 2023 A study presented at the 2022… Read More...
Health How Long Should Myeloma Patients Continue Lenalidomide After AutoSCT? James Pereira Dec 29, 2022 Data from a large phase III trial… Read More...
Health Elranatamab Active in Relapsed or Refractory Multiple Myeloma James Pereira Dec 22, 2022 Data presented at the 2022 American… Read More...
Health Upfront Transplant Prevails Again in Newly Diagnosed Myeloma James Pereira Dec 21, 2022 An… Read More...
Health Experimental cancer therapy shows success in more than 70% of patients in global clinical trials:… James Pereira Dec 14, 2022 A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of… Read More...
Health Talquetamab Offers New Hope in Relapsed/Refractory Multiple Myeloma James Pereira Dec 12, 2022 NEW ORLEANS -- Talquetamab had substantial antitumor… Read More...
Health Caribou Biosciences Announces FDA Clearance of IND Application for CB-011, an Allogeneic Anti-BCMA… James Pereira Nov 21, 2022 -- CaMMouflage Phase 1 clinical trial to initiate patient enrollment at dose level 1 in early 2023 -- -- CB-011 is… Read More...